Analysts See Major Upside for This Drug Stock

The stock's consensus 12-month price target sits in uncharted territory for RYTM

Digital Content Manager
Jul 8, 2019 at 12:43 PM
facebook X logo linkedin


The shares of Rhythm Pharmaceuticals Inc (NASDAQ:RYTM) are getting a boost today, after Canaccord Genuity initiated coverage on the drugmaker with a "buy" rating and a $35 price target -- a more than 60% premium to the stock's current perch. The rating comes just weeks after the stock hit a 14-month low of $20.64, and has RYTM on track to close above its 10-day moving average for the first time since late May.

In fact, the stock, which is now trading up 3.5% at $21.84, hit a two-week high earlier before easing back. Looking further back, RYTM has struggled on the charts, still 19.1% lower year-to-date. While the security has managed to find its footing atop the $21 region, the $22 area has acted as resistance on the charts of late. 

Three analysts agree with Canaccord's "buy" rating, while one brokerage firm calls the stock a "hold." However, the consensus 12-month target price of $37.86 exceeds Canaccord's estimate, and sits in a region never before touched by the security. 

Short sellers started to cash out during the equity's recent technical struggles, with short interest down 6.5% in the latest reporting period. However, the 1.46 million shares sold short still represent a solid 7.7% of the stock's available float, or 13.3 times the average daily pace of trading.

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI